Investigation of risk factors to coronary heart disease in two countryside villages

Brazilian Archives of Biology and Technology

Volumn 47, Issue 3, 2004, Pages 387-390

  Cavalcante Da Silva, Gisleine Elisa ^a   Bazotte, Roberto Barbosa ^a   Curi, Rui ^b   Pereira Da Silva, Maria Angélica Rafaini Covas ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Coronary heart disease Paran State Brazil; Hyperglycemia; Hyperlipidemia; Hypertension; Obesity

Indexed keywords

EID: 19944374500     PISSN: 15168913     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-89132004000300008     Document Type: Article

References (18)

1. Allain, C. C.; Poon, L. S.; Chan, C. S.; Richmond, W. and Fu, P. C. (1974), Enzymatic determination of total serum cholesterol. Clin. Chem., 20, 470-475.
2. Avezum, A.; Neto, J. M. R. and Piegas, L. (1999), Why do we need randomized and epidemiological studies on cardiovascular disease? Evidence-based cardiology VII. Arq. Bras. Cardiol., 72, 281-295.
3. Bazotte, R. B. and Bertolini, G. L. (2001), Fármacos Hipolipemiantes. In: Curi, R.; Pompéia, C.; Miyasaka, C. K. and Procópio, J. (eds.). Entendendo a gordura. Manole, Barueri. pp. 489-506.
4. Bergmeyer, H. U. and Bernt, E. (1974), Determination of glucose with glucose oxidase and peroxidase. In: Bergmeyer, H. U. (ed). Methods of enzymatic analysis. New York : Verlag Chemie-Academic Press. pp. 1205-1215.
5. Cardoso, A. M.; Mattos, I. E. and Koifman, R. J. (2001), Prevalence of risk factors for cardiovascular disease in the Guarani-Mbya population of the State of Rio de Janeiro. Cad. Saúde Pública, 17, 345-354.
6. Despres, J. P.; Lemieux, I. and Prud'homme, D. (2001), Treatment of obesity: need to focus on high risk abdominally obese patients. Br. Med. J., 24, 716-720.
7. Domanski, M.; Norman, J.; Wolz, M.; Mitchell, G. and Pfeffer, M. (2001), Diabetes and atherosclerosis: an epidemiological view. Hypertension, 38, 793-797.
8. Dominiczak, M. H. (1998), Hyperlipidemia and cardiovascular disease. Curr. Opin. Lipidol., 9, 609-611.
9. Idzior-Walus, B.; Mattock, M. B.; Solnica, B.; Stevens, L. and Fuller, J. H. (2001), Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med., 18, 786-796.
10. Klein, S. (2001), Outcome success in obesity. Obes Res., 9, 354-358.
11. Kralikova, E.; Ceska, R. and Rames, J. (1999), Diet, smoking, and blood lipids in patients with combined familial hyperlipidemia. Cent. Eur. J. Public. Health, 7, 219-231.
12. Linde, R. and Linde, B. (2001), Lipids and risk assessment. Cardiol. Rev., 9 : (6), 348-358.
13. McGowan, M. W.; Artiss, J. D.; Strandbergh, D. R. and Zak, B. A. (1983), Peroxidase coupled method for the colorimetric determination of serum triglycerides. Clin. Chem., 29, 538-542.
14. Ounpuu, S.; Negassa, A. and Yusuf, S. (2001), Inter-heart: A global study of risk factors for acute myocardial infarction. Am. Heart J., 141, 711-721.
15. Pavan, L.; Casiglia, E.; Braga, L. M.; Winnicki, M.; Puato, M.; Pauletto, P. and Pessina, A. C. (1999), Effects of a traditional lifestyle on the cardiovascular risk profile: the Amondava population of the Brazilian Amazon. Comparison with matched African, Italian and Polish populations. J. Hypertens., 17, 749-756.
16. Perez, L. H.; Gutierrez, L. A.; Vioque, J. and Torres, Y. (2001), Relation between overweight, diabetes, stress and hypertension: a case-control study in Yarumal-Antioquia, Colombia. Eur. J. Epidemiol., 17, 275-280.
17. Pyolara, K.; Laakso, M. and Uusitupa, M. (1987), Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab. Rev., 3, 463-524.
18. Spanheimer, R. G. (2001), Reducing cardiovascular risk in type 2 diabetes. Which factors to modify first? Postgrad Med., 109, 26-30.